0000899243-20-015822.txt : 20200609 0000899243-20-015822.hdr.sgml : 20200609 20200609164432 ACCESSION NUMBER: 0000899243-20-015822 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200605 FILED AS OF DATE: 20200609 DATE AS OF CHANGE: 20200609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: David Nathaniel E CENTRAL INDEX KEY: 0001559531 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38470 FILM NUMBER: 20952460 MAIL ADDRESS: STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC. STREET 2: 27200 WEST AGOURA ROAD, SUITE 200 CITY: CALABASAS STATE: CA ZIP: 91301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unity Biotechnology, Inc. CENTRAL INDEX KEY: 0001463361 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264726035 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: (415) 328-5504 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Cenexys, Inc. DATE OF NAME CHANGE: 20130703 FORMER COMPANY: FORMER CONFORMED NAME: Forge Inc DATE OF NAME CHANGE: 20090504 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-05 0 0001463361 Unity Biotechnology, Inc. UBX 0001559531 David Nathaniel E C/O UNITY BIOTECHNOLOGY, INC. 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President Common Stock, $0.0001 par value 2020-06-05 4 P 0 3200 8.8994 A 2327186 D Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices vary between $8.8994 and $8.8995 per share. Information on the exact number of shares purchased at each purchase price can be obtained from Issuer upon request. Includes Restricted Stock Units which vest over time measured from the grant date. /s/ Tamara L. Tompkins, Attorney-in-Fact for Nathaniel E. David 2020-06-08